Skip to content

ISA PHARMA: what changed

BE 0835.600.362NACE 47.730, Retail sale of pharmaceutical productsOther company

Position among the sector peers

What moved between 2024 and 2025

Net result for the year
€34,498
2024 · €24,829+€9,670
Equity
€181,475
2024 · €168,044+€13,432
Cash
€146,413
2024 · €121,011+€25,402
Balance sheet total
€346,253
2024 · €311,118+€35,135

Largest movements

2024 to 2025
Assets
  • Cash +€25,402

    up €25,402 (+21.0%), from €121,011 to €146,413

    mainly Net result for the year (+€34,498) and Other debts (+€15,702)

  • Stocks and contracts +€11,285

    up €11,285 (+12.2%), from €92,260 to €103,545

  • Tangible fixed assets -€8,670

    down €8,670 (-11.0%), from €78,750 to €70,080

    of which Land and buildings: -€9,398

  • Receivables within one year +€7,178

    up €7,178 (+58.7%), from €12,224 to €19,401

    of which Trade receivables: +€8,533

Equity and liabilities
  • Other debts +€15,702

    up €15,702 (+230%), from €6,827 to €22,530

  • Reserves +€13,432

    up €13,432 (+9.6%), from €140,455 to €153,887

    of which Distributable reserves: +€13,432

  • Debts after one year -€9,966

    down €9,966 (-14.4%), from €69,416 to €59,450

  • Tax, wage and social debts +€8,340

    up €8,340 (+36.1%), from €23,119 to €31,459

    of which Taxes: +€7,131

  • Trade debts +€7,233

    up €7,233 (+23.2%), from €31,139 to €38,373

Income statement
  • Gross operating margin +€12,327

    up €12,327 (+6.2%), from €197,473 to €209,801

  • Taxes +€4,078

    up €4,078 (+42.3%), from €9,645 to €13,723

Change in the result, 2024 to 2025

effect on the result

For each income-statement line you see the change as its effect on the result. Higher costs lower the result, higher income raises it.

Result 2024 €24,829
Gross operating margin +€12,327
Staff costs +€1,855
Depreciation -€134
Other operating charges -€41
Financial income -€497
Financial charges +€238
Taxes -€4,078
Result 2025 €34,498
raises the resultlowers the result

Derived cash bridge

cash 2024 to 2025

The bridge is derived from the 2024 and 2025 balance sheets and the 2025 result. There is no filed cash-flow statement. You see where the money came from and where it went.

From operations +€57,592
Investment -€1,551
Financing -€30,638
Cash 2024 €121,011
Net result for the year +€34,498
Depreciation +€10,221
Stocks and contracts -€11,285
Receivables within one year -€7,178
Deferred charges and accrued income +€60
Trade debts +€7,233
Tax, wage and social debts +€8,340
Other debts +€15,702
Investment in fixed assets (net) -€1,551
Debts after one year -€9,966
Current portion of long-term debt +€394
Contributions, distributions and other -€21,067
Cash 2025 €146,413
brings cash intakes cash out
Every line side by side 58 lines
Line Code 2024 2025 Change %
Total assets 20/58 €311,118 €346,253 +€35,135 +11.3%
Formation expenses 20 €0 €0 =
Fixed assets 21/28 €85,528 €76,858 -€8,670 -10.1%
Intangible fixed assets 21 €0 €0 =
Tangible fixed assets 22/27 €78,750 €70,080 -€8,670 -11.0%
Land and buildings 22 €76,771 €67,373 -€9,398 -12.2%
Plant, machinery and equipment 23 €351 €1,720 +€1,369 +390%
Furniture and vehicles 24 €1,628 €987 -€641 -39.4%
Financial fixed assets 28 €6,779 €6,779 = 0.0%
Current assets 29/58 €225,589 €269,395 +€43,805 +19.4%
Stocks and contracts in progress 3 €92,260 €103,545 +€11,285 +12.2%
Stocks 30/36 €92,260 €103,545 +€11,285 +12.2%
Amounts receivable within one year 40/41 €12,224 €19,401 +€7,178 +58.7%
Trade receivables 40 €10,869 €19,401 +€8,533 +78.5%
Other amounts receivable 41 €1,355 €0 -€1,355 -100%
Cash at bank and in hand 54/58 €121,011 €146,413 +€25,402 +21.0%
Deferred charges and accrued income 490/1 €95 €35 -€60 -63.2%
Total equity and liabilities 10/49 €311,118 €346,253 +€35,135 +11.3%
Equity 10/15 €168,044 €181,475 +€13,432 +8.0%
Contributions 10/11 €14,260 €14,260 = 0.0%
Reserves 13 €140,455 €153,887 +€13,432 +9.6%
Non-distributable reserves 130/1 €0 €0 =
Reserves not available under the articles 1311 €0 €0 =
Tax-exempt reserves 132 €0 €0 =
Distributable reserves 133 €140,455 €153,887 +€13,432 +9.6%
Profit (loss) carried forward 14 €13,329 €13,329 = 0.0%
Provisions and deferred taxes 16 €0 €0 =
Provisions for liabilities and charges 160/5 €0 €0 =
Major repairs and maintenance 162 €0 €0 =
Other liabilities and charges 164/5 €0 €0 =
Amounts payable 17/49 €143,074 €164,778 +€21,704 +15.2%
Amounts payable after more than one year 17 €69,416 €59,450 -€9,966 -14.4%
Financial debts 170/4 €69,416 €59,450 -€9,966 -14.4%
Amounts payable within one year 42/48 €73,658 €105,327 +€31,669 +43.0%
Current portion of amounts payable after more than one year 42 €12,572 €12,966 +€394 +3.1%
Trade debts 44 €31,139 €38,373 +€7,233 +23.2%
Suppliers 440/4 €31,139 €38,373 +€7,233 +23.2%
Taxes, remuneration and social security 45 €23,119 €31,459 +€8,340 +36.1%
Taxes 450/3 €2,143 €9,274 +€7,131 +333%
Remuneration and social security 454/9 €20,977 €22,186 +€1,209 +5.8%
Other amounts payable 47/48 €6,827 €22,530 +€15,702 +230%
Accrued charges and deferred income 492/3 €0 €0 =
Remuneration, social security and pensions 62 €147,993 €146,138 -€1,855 -1.3%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €10,088 €10,221 +€134 +1.3%
Provisions for liabilities and charges: additions (uses and reversals) 635/8 €0 €0 =
Other operating charges 640/8 €1,995 €2,036 +€41 +2.1%
Non-recurring operating charges 66A €0 €0 =
Gross operating margin 9900 €197,473 €209,801 +€12,327 +6.2%
Operating profit (loss) 9901 €37,398 €51,405 +€14,007 +37.5%
Financial income 75/76B €1,505 €1,008 -€497 -33.0%
Recurring financial income 75 €1,505 €1,008 -€497 -33.0%
Financial charges 65/66B €4,429 €4,191 -€238 -5.4%
Recurring financial charges 65 €4,429 €4,191 -€238 -5.4%
Profit (loss) for the period before taxes 9903 €34,474 €48,222 +€13,748 +39.9%
Income taxes 67/77 €9,645 €13,723 +€4,078 +42.3%
Profit (loss) for the period 9904 €24,829 €34,498 +€9,670 +38.9%
Transfer from tax-exempt reserves 789 €0 €0 =
Profit (loss) for the period to be appropriated 9905 €24,829 €34,498 +€9,670 +38.9%

Value

latest balance sheet 31-12-2025 · indication, not a valuation or advice

Indicative value of the equity

Indication, not a valuation or advice
€197,259 to €239,868

Midpoint €215,013 · 50% capitalised earnings, 50% adjusted equity

Capitalisation rate 12% result over 3 years earnings weight 50%

Worked out with Checked's starting values, not your estimate and not market data. Change the assumptions: the value follows.

Adjusted equity €181,475
Capitalised earnings €213,043 to €298,260
Indication €197,259 to €239,868

Adjusted equity

balance sheet 31-12-2025
Equity (10/15)
€181,475
Revaluation of assets
€0
Deferred tax on the revaluation
€0
Other adjustment
€0
Adjusted equity
€181,475

Capitalised earnings

net result for the year (9904)
2025
€34,498
2024
€24,829
2023
€30,151
2022
€52,502
2021
€16,031
Average result
€29,826
Divided by the capitalisation rate
14% / 12% / 10%
Capitalised earnings
€213,043 / €248,550 / €298,260

Limits of the indication

  • Checked holds no market prices or comparable transactions.
  • Anything after the latest accounts and items off the balance sheet (guarantees, leases, disputes) are left out.
  • Checked does not know the real value of buildings, stock and receivables. Enter your own revaluation or adjustment for it.
  • The result is not corrected for the manager's pay. If the company pays less or more than a market salary, the capitalised earnings are too high or too low.
  • The owner's role in the business, synergies for a buyer and the tax consequences of a sale are left out.

For a valuation to base a decision on, go to a company auditor or a certified accountant.

Calculation and sources

Source: filed annual accounts (NBB) and main activity (KBO). The movements compare the financial years ended 31 December 2024 and 31 December 2025. Green is a favourable move for that line, red an unfavourable one. The value is an indication, not a valuation or advice. Prepared on 18 November 2026 via checked.be.